Gogoi, Mayuri
Qureshi, Irtiza
Chaloner, Jonathan
Al-Oraibi, Amani
Reilly, Holly
Wobi, Fatimah
Agbonmwandolor, Joy Oghogho
Ekezie, Winifred
Hassan, Osama
Lal, Zainab
Kapilashrami, Anuj
Nellums, Laura
Pareek, Manish
Gray, Laura
Guyatt, Anna L
Johns, Catherine
McManus, Chris I
Woolf, Katherine
Abubakar, Ibrahim
Gupta, Amit
Abrams, Keith R
Tobin, Martin D
Wain, Louise
Carr, Sue
Dove, Edward
Khunti, Kamlesh
Ford, David
Free, Robert
,
Funding for this research was provided by:
MRC-UK Research and Innovation (MR/ V027549/1, MR/ V027549/1, MR/ V027549/1, MR/ V027549/1, MR/ V027549/1, MR/ V027549/1, MR/ V027549/1, MR/ V027549/1, MR/ V027549/1, MR/ V027549/1)
Article History
Received: 19 June 2023
Accepted: 14 May 2024
First Online: 23 May 2024
Declarations
:
: The study received ethical approval from the London-Brighton & Sussex Research Ethics Committee of the Health Research Authority (Ref No 20/HRA/4718). All participants provided written informed consent.
: Not applicable.
: MP reports grants from Sanofi, grants and personal fees from Gilead Sciences and personal fees from QIAGEN, outside the submitted work. MG, IQ, JC, AAO, HR, FW, JOA, WE, OH, ZL, AK and LBN, have no competing interests to declare.